Difficulty: Medium
Average Score: 79%
Practice
A 50-year-old woman with a positive mammogram undergoes lumpectomy and a small carcinoma is removed. Biochemical analysis of the cancer reveals the presence of estrogen and progesterone receptors. After this procedure, she will probably receive
Correct answer
C
Rationale
The correct answer is C) Tamoxifen. In this scenario, the presence of estrogen and progesterone receptors in the carcinoma indicates that the cancer is hormone receptor-positive. Tamoxifen is a selective estrogen receptor modulator (SERM) that works by blocking the estrogen receptors in breast cancer cells, thereby inhibiting the growth of hormone-sensitive tumors.
Danazol (A) is used for conditions like endometriosis and fibrocystic breast disease, not for hormone receptor-positive breast cancer. Flutamide (B) is an antiandrogen used in the treatment of prostate cancer, not breast cancer. Mifepristone (D) is a medication used for medical abortion and Cushing's syndrome, not for hormone receptor-positive breast cancer.
Educationally, understanding the mechanism of action of drugs in treating hormone-sensitive tumors is crucial in oncology. It is important for healthcare professionals to be able to differentiate between drugs targeting different receptors to provide the most effective treatment for patients with specific types of cancer. This knowledge can significantly impact patient outcomes and quality of life.
Danazol (A) is used for conditions like endometriosis and fibrocystic breast disease, not for hormone receptor-positive breast cancer. Flutamide (B) is an antiandrogen used in the treatment of prostate cancer, not breast cancer. Mifepristone (D) is a medication used for medical abortion and Cushing's syndrome, not for hormone receptor-positive breast cancer.
Educationally, understanding the mechanism of action of drugs in treating hormone-sensitive tumors is crucial in oncology. It is important for healthcare professionals to be able to differentiate between drugs targeting different receptors to provide the most effective treatment for patients with specific types of cancer. This knowledge can significantly impact patient outcomes and quality of life.